Integration of prescription drug monitoring programs (PDMP) in pharmacy practice: Improving clinical decision-making and supporting a pharmacist's professional judgment

Research in Social and Administrative Pharmacy

Volumn 12, Issue 2, 2016, Pages 257-266

  Norwood, Connor W ^a,b   Wright, Eric R ^a,c  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Corresponding responsibility; Drug diversion; Opioid addiction; PDMP; Pharmacists; Pharmacy; Pharmacy administration; Prescription drug abuse; Prescription drug monitoring

Indexed keywords

CONTROLLED SUBSTANCE; PRESCRIPTION DRUG;

ADULT; CLINICAL DECISION MAKING; DECISION MAKING; DRUG UTILIZATION; FEMALE; HUMAN; INDIANA; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PHARMACIST; PHARMACY; PRESCRIPTION DRUG MISUSE;

ADULT; CLINICAL DECISION-MAKING; CONTROLLED SUBSTANCES; DRUG UTILIZATION; FEMALE; HUMANS; INDIANA; JUDGMENT; MALE; MIDDLE AGED; PHARMACEUTICAL SERVICES; PHARMACISTS; PRESCRIPTION DRUG MISUSE; PRESCRIPTION DRUGS;

EID: 84959548723     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2015.05.008     Document Type: Article

References (18)

1. Centers for Disease Control and Prevention. 2013 Drug Overdose Mortality Data Announced. Prescription Opioid Deaths Level; Heroin-related Deaths Rise; 2015.
2. Centers for Disease Control Prevention. CDC grand rounds: prescription drug overdoses-a U.S. epidemic. MMWRMorbMortalWkly Rep 2012;61:10-13.
3. Compton WM, Thomas YF, Conway KP, Colliver JD. Developments in the epidemiology of drug use and drug use disorders. Am J Psychiatry 2005;162:1494-1502.
4. Drug Enforcement Administration Office of Diversion Control. Pharmacist's Manual: An Informational Outline of the Controlled Substances Act; 2010.
5. Cote L. A Pharmacist's Obligation: Corresponding Responsibility and Red Flags of Diversion. DEA Chronicles: Quarles & Brady LLP; 2013.
6. Prescriptions. In: Drug Enforcement Administration, ed. 21 C.F.R. x 1306. 2014.
7. Bartels C. Analysis of Experienced Pharmacist Clinical Decision-making Fro Drug Therapy Management in the Ambulatory Care Setting. University of Minnesota Digital Conservancy, University of Minnesota; 2013.
8. NAMSDL. The Role of a Prescription Drug Monitoring Program in Reducing Prescription Drug Diversion, Misuse, and Abuse. National Alliance for Model State Drug Laws; 2014.
9. Blumenschein K, Fink J, Freeman PR, et al. Review of Prescription Drug Monitoring Programs in the United States. Institute for Pharmaceutical Outcomes and Policy; 2010. p. 1-28.
10. PDMP Center of Excellence. Briefing on PDMP Effectiveness. Brandeis University: Bureau of Justice Assistance; 2014.
11. Indiana Professional Licensing Agency. What Sort of Information is Collected by INSPECT?; 2014. IN.gov.
12. Kooreman H, Carnes N, Wright E. Key Findings and Recommendations From the 2013 IPLA INSPECT Knowledge and Use Survey. Center for Health Policy: Indiana University; 2014.
13. Fleming ML, Barner JC, Brown CM, Shepherd MD, Strassels SA, Novak S. Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions. J Am Pharm Assoc 2014;54:241-250.
14. Green TC, Mann MR, Bowman SE, et al. How does use of a prescription monitoring program change pharmacy practice? J Am Pharm Assoc 2013;53: 273-281.
15. Maxey HL. Indiana Pharmacist 2012 Licensure Survey Data. In: Indiana University Health Workforce Studies; 2015.
16. Menard S. Applied Logistic Regression Analysis. Thousand Oaks, CA: Sage; 2002.
17. Behavioral Health Coordinating Committee. Addressing Prescription Drug Abuse in the United States: Current Activities and Future Opportunities. Centers for Disease Control and Prevention; 2013.
18. Maxwell L, Odukoya OK, Stone JA, Chui MA. Using a conflict conceptual framework to describe challenges to coordinated patient care from the physicians' and pharmacists' perspective. Res Soc Adm Pharm 2014;10:824-836.